Citigroup’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
35,319
-19,390
| -35% | -$69.8K | ﹤0.01% | 3577 |
|
|
2025
Q1 | $164K | Sell |
54,709
-6,225
| -10% | -$18.6K | ﹤0.01% | 3547 |
|
|
2024
Q4 | $204K | Buy |
60,934
+3,101
| +5% | +$10.4K | ﹤0.01% | 3571 |
|
|
2024
Q3 | $194K | Buy |
57,833
+38,636
| +201% | +$129K | ﹤0.01% | 3598 |
|
|
2024
Q2 | $63.5K | Buy |
19,197
+4,420
| +30% | +$14.6K | ﹤0.01% | 3728 |
|
|
2024
Q1 | $59.7K | Buy |
14,777
+2,284
| +18% | +$9.23K | ﹤0.01% | 3798 |
|
|
2023
Q4 | $38.1K | Buy |
12,493
+11,418
| +1,062% | +$34.8K | ﹤0.01% | 3914 |
|
|
2023
Q3 | $3.23K | Sell |
1,075
-40,729
| -97% | -$122K | ﹤0.01% | 4094 |
|
|
2023
Q2 | $156K | Buy |
41,804
+38,973
| +1,377% | +$146K | ﹤0.01% | 3352 |
|
|
2023
Q1 | $9.48K | Sell |
2,831
-5,357
| -65% | -$17.9K | ﹤0.01% | 4090 |
|
|
2022
Q4 | $39.4K | Sell |
8,188
-11,219
| -58% | -$54K | ﹤0.01% | 3658 |
|
|
2022
Q3 | $110K | Buy |
19,407
+246
| +1% | +$1.39K | ﹤0.01% | 3344 |
|
|
2022
Q2 | $136K | Sell |
19,161
-2,526
| -12% | -$17.9K | ﹤0.01% | 3385 |
|
|
2022
Q1 | $157K | Sell |
21,687
-19,280
| -47% | -$140K | ﹤0.01% | 3524 |
|
|
2021
Q4 | $366K | Buy |
40,967
+33,318
| +436% | +$298K | ﹤0.01% | 3255 |
|
|
2021
Q3 | $268K | Buy |
7,649
+4,209
| +122% | +$147K | ﹤0.01% | 3237 |
|
|
2021
Q2 | $74K | Sell |
3,440
-1,557
| -31% | -$33.5K | ﹤0.01% | 3964 |
|
|
2021
Q1 | $309K | Buy |
4,997
+2,250
| +82% | +$139K | ﹤0.01% | 3121 |
|
|
2020
Q4 | $115K | Buy |
+2,747
| New | +$115K | ﹤0.01% | 3590 |
|